Ozempic (Semaglutide) NDC 0169-4181

Product information

Brand name (proprietary)

Ozempic

Generic name (nonproprietary)

semaglutide

Active ingredients

Semaglutide — .68 mg/mL

Dosage form

Injection, Solution

Route

Subcutaneous

Labeler

Novo Nordisk Pharmaceutical Industries, LPNDC labeler code 0169

Product type

Prescription drug

Marketing category

NDA — New Drug ApplicationApplication NDA 209637

Marketing start

Oct 7, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Glucagon-Like Peptide 1 (Chemical structure)Glucagon-like Peptide-1 (GLP-1) Agonists (Mechanism)

Identifiers

Product ID 0169-4181_5e1477c5-c1b8-4fc5-af2a-83e5d356a77dSPL ID 5e1477c5-c1b8-4fc5-af2a-83e5d356a77d

Pharmacologic class

GLP-1 Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

No drug-specific HCPCS code in Med-Code’s directory for this product.

Med-Code's directory has no drug-specific HCPCS code for Ozempic. It is usually self-administered and billed by NDC through a pharmacy benefit.

If a payer accepts an unclassified code for it in a clinical setting, that would be J3490 (Unclassified drugs), with the NDC, quantity and often the invoice. Acceptance varies by payer.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400169418113 followed by a unit qualifier and the quantity Copy

Package 00169-4181-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0169-4181

What is NDC 0169-4181?

0169-4181 is the product NDC for Ozempic (semaglutide), Semaglutide .68 mg/mL injection, solution, listed with the FDA by Novo Nordisk Pharmaceutical Industries, LP. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Ozempic (Semaglutide).

What is the active ingredient?

Semaglutide.

Who is the labeler?

Novo Nordisk Pharmaceutical Industries, LP, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ozempic?

8 other product NDCs are listed under this name. See all Ozempic NDCs.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory. See Billing references above.

Related NDCs: other Ozempic products

Other finished products listed under the same name: strengths, forms and labelers.

Other NDCs under NDA 209637

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.